The mammalian cell lines that are engineered to produce high-value recombinant-protein drugs also produce unwanted proteins that push up the overall cost to manufacture these drugs. These same proteins can also lower drug quality. Researchers have now shown that their genome-editing techniques could eliminate up to 70 percent of the contaminating protein by mass in recombinant-protein drugs produced by the workhorses of mammalian cells -- Chinese Hamster Ovary (CHO) cells.
from Top Technology News -- ScienceDaily https://ift.tt/2VuXxl7
Thursday, 23 April 2020
Researchers are making recombinant-protein drugs cheaper
About Unknown
Magazine Power Theme is officially developed by Templatezy Team. We published High quality Blogger Templates with Awesome Design for blogspot lovers.The very first Blogger Templates Company where you will find Responsive Design Templates.
Subscribe to:
Post Comments (Atom)
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean. 
SOCIALIZE IT →